Home›Companies›Biotech & Pharma›Inanovate

Inanovate Inc.

Updated Oct 29, 2026·Latest SEC filing Jul 2, 2025·Suggest an edit

About Inanovate

Inanovate is a private company based in Sioux Falls, South Dakota. It has reported $12,952,638 raised in ten offerings on Form D since December 2015.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 26, 2025Jul 2, 2025$808,000fully sold2$404KEquityRule 506(b)Form D ↗
Nov 8, 2024Nov 15, 2024$900,000fully sold6$150KEquityRule 506(b)Form D ↗
May 20, 2024Jun 12, 2024$1,100,000of $2.5M target4$275KEquityRule 506(b)Form D ↗
Dec 8, 2023Dec 11, 2023$1,500,000of $3.0M target3$500KEquityRule 506(b)Form D ↗
Oct 5, 2022Oct 6, 2022$2,390,000of $3.0M target7$341KEquityRule 506(b)Form D ↗
Feb 14, 2022Feb 23, 2022$1,807,117fully sold11$164KEquityRule 506(b)Form D ↗
Jul 3, 2020Jul 13, 2020$455,260fully sold6$75,877Equity, OptionsRule 506(b)Form D ↗
Nov 5, 2019Nov 18, 2019$439,244fully sold3$146KEquityRule 506(b)Form D ↗
Feb 15, 2019Feb 19, 2019$3,050,609fully sold5$610KEquityRule 506(b)Form D ↗
Dec 2, 2015Dec 17, 2015$502,408of $2.0M target5$100KEquityRule 506(b)Form D ↗
Total, ten offerings$12,952,638

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Inanovate's Form D filed Jul 2, 2025.

DU
David Ure
Executive officer and director
PL
Peter Los
Director
GH
BC
DA
JO
James Oury
Executive officer
KP

Earlier filings also listed Kent Lehr (director, last listed Oct 2022), Kamran Tahamtanzade (director, last listed Oct 2022), Michael Goldstein (director, last listed Feb 2022) and Randall Marfin (board member, last listed Dec 2015).

Sources

  1. SECINANOVATE INC filing history